542 related articles for article (PubMed ID: 28215569)
1. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.
Bhonsale A; Te Riele ASJM; Sawant AC; Groeneweg JA; James CA; Murray B; Tichnell C; Mast TP; van der Pols MJ; Cramer MJM; Dooijes D; van der Heijden JF; Tandri H; van Tintelen JP; Judge DP; Hauer RNW; Calkins H
Heart Rhythm; 2017 Jun; 14(6):883-891. PubMed ID: 28215569
[TBL] [Abstract][Full Text] [Related]
2. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
[TBL] [Abstract][Full Text] [Related]
3. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.
Bhonsale A; Groeneweg JA; James CA; Dooijes D; Tichnell C; Jongbloed JD; Murray B; te Riele AS; van den Berg MP; Bikker H; Atsma DE; de Groot NM; Houweling AC; van der Heijden JF; Russell SD; Doevendans PA; van Veen TA; Tandri H; Wilde AA; Judge DP; van Tintelen JP; Calkins H; Hauer RN
Eur Heart J; 2015 Apr; 36(14):847-55. PubMed ID: 25616645
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
[TBL] [Abstract][Full Text] [Related]
5. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
Protonotarios A; Anastasakis A; Panagiotakos DB; Antoniades L; Syrris P; Vouliotis A; Stefanadis C; Tsatsopoulou A; McKenna WJ; Protonotarios N
Europace; 2016 Apr; 18(4):610-6. PubMed ID: 25825460
[TBL] [Abstract][Full Text] [Related]
6. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
[TBL] [Abstract][Full Text] [Related]
7. Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy.
Bao J; Wang J; Yao Y; Wang Y; Fan X; Sun K; He DS; Marcus FI; Zhang S; Hui R; Song L
Circ Cardiovasc Genet; 2013 Dec; 6(6):552-6. PubMed ID: 24125834
[TBL] [Abstract][Full Text] [Related]
8. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
[TBL] [Abstract][Full Text] [Related]
9. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
[TBL] [Abstract][Full Text] [Related]
10. Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis.
Antoniades L; Tsatsopoulou A; Anastasakis A; Syrris P; Asimaki A; Panagiotakos D; Zambartas C; Stefanadis C; McKenna WJ; Protonotarios N
Eur Heart J; 2006 Sep; 27(18):2208-16. PubMed ID: 16893920
[TBL] [Abstract][Full Text] [Related]
11. Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry.
Choudhary N; Tompkins C; Polonsky B; McNitt S; Calkins H; Mark Estes NA; Krahn AD; Link MS; Marcus FI; Towbin JA; Zareba W
J Cardiovasc Electrophysiol; 2016 May; 27(5):555-62. PubMed ID: 26840461
[TBL] [Abstract][Full Text] [Related]
12. Late presentation of arrhythmogenic right ventricular cardiomyopathy in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene: a case report.
Adachi Y; Hayashi T; Mitsuhashi T; Sakakura K; Yamada Y; Wada Y; Horie M; Momomura SI; Fujita H
BMC Cardiovasc Disord; 2019 Feb; 19(1):41. PubMed ID: 30782136
[TBL] [Abstract][Full Text] [Related]
13. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
te Riele AS; Bhonsale A; James CA; Rastegar N; Murray B; Burt JR; Tichnell C; Madhavan S; Judge DP; Bluemke DA; Zimmerman SL; Kamel IR; Calkins H; Tandri H
J Am Coll Cardiol; 2013 Nov; 62(19):1761-9. PubMed ID: 23810894
[TBL] [Abstract][Full Text] [Related]
14. Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa.
Watkins DA; Hendricks N; Shaboodien G; Mbele M; Parker M; Vezi BZ; Latib A; Chin A; Little F; Badri M; Moolman-Smook JC; Okreglicki A; Mayosi BM;
Heart Rhythm; 2009 Nov; 6(11 Suppl):S10-7. PubMed ID: 19880068
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic analysis of arrhythmogenic cardiomyopathy in the Hutterite population: role of electrocardiogram in identifying high-risk desmocollin-2 carriers.
Wong JA; Duff HJ; Yuen T; Kolman L; Exner DV; Weeks SG; Gerull B
J Am Heart Assoc; 2014 Dec; 3(6):e001407. PubMed ID: 25497880
[TBL] [Abstract][Full Text] [Related]
16. Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Saguner AM; Vecchiati A; Baldinger SH; Rüeger S; Medeiros-Domingo A; Mueller-Burri AS; Haegeli LM; Biaggi P; Manka R; Lüscher TF; Fontaine G; Delacrétaz E; Jenni R; Held L; Brunckhorst C; Duru F; Tanner FC
Circ Cardiovasc Imaging; 2014 Mar; 7(2):230-9. PubMed ID: 24515411
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile in arrhythmogenic cardiomyopathy and a recessive plakophilin-2 gene mutation.
Ali M; Bhat IA; Hafeez I; Dar MI; Beig JR; Shah ZA; Iqbal K
Indian Heart J; 2018; 70(3):421-426. PubMed ID: 29961461
[TBL] [Abstract][Full Text] [Related]
18. Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy.
Perrin MJ; Angaran P; Laksman Z; Zhang H; Porepa LF; Rutberg J; James C; Krahn AD; Judge DP; Calkins H; Gollob MH
J Am Coll Cardiol; 2013 Nov; 62(19):1772-9. PubMed ID: 23810883
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.
Sen-Chowdhry S; Syrris P; Ward D; Asimaki A; Sevdalis E; McKenna WJ
Circulation; 2007 Apr; 115(13):1710-20. PubMed ID: 17372169
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
